{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:45:25Z","timestamp":1774673125226,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Semin Surg Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Background<\/jats:title>\n                        <jats:p>The IgG autoantibody ANNA-2 (anti-Ri) is a type 2 antineuronal antibody that has been found to bind to highly conserved and widely distributed adult brain proteins encoded by the <jats:italic>Nova-1<\/jats:italic> and <jats:italic>Nova-2<\/jats:italic> genes. Anti-Ri antibodies are typically detected in the serum and cerebrospinal fluids of patients with neurological disorders such as opsoclonus\/myoclonus and cerebellar ataxia and in association with gynecologic and breast malignancies.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Case Presentation<\/jats:title>\n                        <jats:p>This report describes an unusual example of a 33-year-old female patient who developed short-term memory deficits over a 3-month period. An extensive neurological work-up, including a panel of paraneoplastic markers was negative with the exception of a high titer serum Anti-Ri (1:15,3600). A large left ovarian mass was palpated, surgically resected and eventually diagnosed as a mature cystic teratoma. Post-operatively, memory deficits had disappeared within 1 month and serum Anti-Ri titers had decreased significantly to 1:256. An extensive diagnostic work-up for other malignancies was negative.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Although, Anti-Ri antibodies are typically associated with malignancies, this case illustrates the potential association between benign tumors and this autoantibody.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/1477-7800-1-11","type":"journal-article","created":{"date-parts":[[2004,11,16]],"date-time":"2004-11-16T07:24:20Z","timestamp":1100589860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary"],"prefix":"10.1186","volume":"1","author":[{"given":"Oluwole","family":"Fadare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan J","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,10]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archneur.61.1.30","volume":"61","author":"RB Darnell","year":"2004","unstructured":"Darnell RB: Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol. 2004, 61: 30-32. 10.1001\/archneur.61.1.30.","journal-title":"Arch Neurol"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMra023009","volume":"349","author":"RB Darnell","year":"2003","unstructured":"Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Eng J Med. 2003, 349: 1543-1554. 10.1056\/NEJMra023009.","journal-title":"N Eng J Med"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0733-8619(02)00037-3","volume":"21","author":"L Bataller","year":"2003","unstructured":"Bataller L, Dalmau J: Paraneoplastic neurologic syndromes. Neurol Clin. 2003, 21: 221-247.","journal-title":"Neurol Clin"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/brain\/awf178","volume":"125","author":"IK Hart","year":"2002","unstructured":"Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR: Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002, 125: 1887-1895. 10.1093\/brain\/awf178.","journal-title":"Brain"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ana.410230518","volume":"23","author":"C Budde-Steffen","year":"1988","unstructured":"Budde-Steffen C, Anderson NE, Rosenblaum MK, Grause F, Ford D, Synek BJ, Wray SH, Posner JB: An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol. 1988, 23: 528-531.","journal-title":"Ann Neurol"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.410290303","volume":"29","author":"FA Luque","year":"1991","unstructured":"Luque FA, Furneaux HM, Ferziger R, Rosenblaum MK, Wray SH, Schold SC, Glantz MJ, Jaeckle KA, Biran H, Lesser M: Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann Neurol. 1991, 29: 241-251.","journal-title":"Ann Neurol"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0304-3940(93)90538-V","volume":"150","author":"F Graus","year":"1993","unstructured":"Graus F, Rowe G, Fueyo J, Darnell RB, Dalmau J: The neuronal nuclear antigen recognized by the anti-Ri autoantibody is expressed in the central but not peripheral nervous system neurons. Neurosci Lett. 1993, 150: 212-214. 10.1016\/0304-3940(93)90538-V.","journal-title":"Neurosci Lett"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","volume":"61","author":"J Honnorat","year":"1996","unstructured":"Honnorat J, Antoine JC, Derrington E, Aguera M, Belin MF: Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 1996, 61: 270-278.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"13254","DOI":"10.1073\/pnas.95.22.13254","volume":"95","author":"YY Yang","year":"1998","unstructured":"Yang YY, Yin GL, Darnell RB: The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc Natl Acad Sci USA. 1998, 95: 13254-13259. 10.1073\/pnas.95.22.13254.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.10518","volume":"53","author":"SJ Pittock","year":"2003","unstructured":"Pittock SJ, Lucchinetti CF, Lennon VA: Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol. 2003, 53: 580-587. 10.1002\/ana.10518.","journal-title":"Ann Neurol"}],"container-title":["International Seminars in Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7800-1-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1477-7800-1-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7800-1-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T13:08:13Z","timestamp":1728306493000},"score":1,"resource":{"primary":{"URL":"https:\/\/issoonline.biomedcentral.com\/articles\/10.1186\/1477-7800-1-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,10]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1186\/1477-7800-1-11","relation":{},"ISSN":["1477-7800"],"issn-type":[{"value":"1477-7800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,10]]},"assertion":[{"value":"29 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}